Home  /  Resource Library  /  SAFETY AND EFFICACY OF DOSE-MODIFIED APPROACHES OF FIXED-DURATION (FD) IBRUTINIB+VENETOCLAX (I+V) IN PATIENTS WITH PREVIOUSLY UNTREATED CLL: PRIMARY ANALYSIS OF THE PROSPECTIVE PHASE 2 TAILOR STUDY

SAFETY AND EFFICACY OF DOSE-MODIFIED APPROACHES OF FIXED-DURATION (FD) IBRUTINIB+VENETOCLAX (I+V) IN PATIENTS WITH PREVIOUSLY UNTREATED CLL: PRIMARY ANALYSIS OF THE PROSPECTIVE PHASE 2 TAILOR STUDY

EHA 2026